Discover
XFOR
X4 Pharmaceuticals, Inc.
4.08
2 x 3.32
2 x 5.22
bid
ask
-
0.58
12.53%
2 @ 04:00 PM
4.20 +0.12 (2.82%)
| Ytd | 2.12% | |
| 1y | 119.62% |
4.06
day range
4.70
1.35
52 week range
4.83
| Open | 4.64 | Prev Close | 4.67 | Low | 4.06 | High | 4.70 | Mkt Cap | 385.30M |
| Vol | 806.77K | Avg Vol | 592.69K | EPS | -2.07 | P/E | N/A | Forward P/E | -1.23 |
| Beta | 0.39 | Short Ratio | 8.64 | Inst. Own | 67.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.09 | 200-d Avg | 3.80 | 1yr Est | 3.05 |
XFOR News
globenewswire.com
X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directo
BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on im
benzinga.com
Leerink Partners Initiates Coverage On X4 Pharmaceuticals with Outperform Rating, Announces Price Ta
Leerink Partners analyst Thomas Smith initiates coverage on X4 Pharmaceuticals (NASDAQ:XFOR) with